Pages that link to "Item:Q8449"
Jump to navigation
Jump to search
The following pages link to Targeting cancer stem cell pathways for cancer therapy (DOI: 10.1038/s41392-020-0110-5) (Q8449):
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Hongjuan Cui (11th author of 10.1038/s41392-020-0110-5) (Q8461) (← links)
- Section 1: Introduction (from DOI: 10.1038/s41392-020-0110-5) (Q8462) (← links)
- Section 2: The concept of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8463) (← links)
- Section 2.1: Biological characteristics of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8464) (← links)
- Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8465) (← links)
- Section 3: Factors regulating CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8466) (← links)
- Section 3.1: Major transcription factors in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8467) (← links)
- Section 3.2: Major signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8468) (← links)
- Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8469) (← links)
- Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8470) (← links)
- Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8471) (← links)
- Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8472) (← links)
- Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5) (Q8473) (← links)
- Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8474) (← links)
- Section 3.2.7PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8475) (← links)
- Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8476) (← links)
- Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8477) (← links)
- Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8478) (← links)
- Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8479) (← links)
- Section 3.3.2: The hypoxia microenvironment and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8480) (← links)
- Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8481) (← links)
- Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8482) (← links)
- Section 3.3.5: Cancer-associated MSCs and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8483) (← links)
- Section 3.3.6: Extracellular matrix and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8484) (← links)
- Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8485) (← links)
- Section 4: Therapeutic targeting of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8486) (← links)
- Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5) (Q8487) (← links)
- Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5) (Q8488) (← links)
- Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5) (Q8489) (← links)
- Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5) (Q8490) (← links)
- Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5) (Q8491) (← links)
- Competing interests (from DOI: 10.1038/s41392-020-0110-5) (Q8492) (← links)
- Siegel RL, et al. CA Cancer J. Clin. (2019) cited as Ref 1 in DOI: 10.1038/s41392-020-0110-5 (Q9264) (← links)
- Sun Y, et al. Med. Res. Rev. (2015) cited as Ref 2 in DOI: 10.1038/s41392-020-0110-5 (Q9265) (← links)
- Batlle E, et al. Nat. Med. (2017) cited as Ref 3 in DOI: 10.1038/s41392-020-0110-5 (Q9266) (← links)
- Reya T, et al. Nature (2001) cited as Ref 4 in DOI: 10.1038/s41392-020-0110-5 (Q9267) (← links)
- Chen W, et al. Stem Cells Int. (2016) cited as Ref 5 in DOI: 10.1038/s41392-020-0110-5 (Q9268) (← links)
- Lapidot T, et al. Nature (1994) cited as Ref 6 in DOI: 10.1038/s41392-020-0110-5 (Q9269) (← links)
- Bonnet D, et al. Nat. Med. (1997) cited as Ref 7 in DOI: 10.1038/s41392-020-0110-5 (Q9270) (← links)
- Shimokawa M, et al. Nature (2017) cited as Ref 8 in DOI: 10.1038/s41392-020-0110-5 (Q9271) (← links)
- Shibata M, et al. Cancers (2019) cited as Ref 9 in DOI: 10.1038/s41392-020-0110-5 (Q9272) (← links)
- Visvader JE, et al. Cell Stem Cell (2012) cited as Ref 10 in DOI: 10.1038/s41392-020-0110-5 (Q9273) (← links)
- Ajani JA, et al. Semin. Oncol. (2015) cited as Ref 11 in DOI: 10.1038/s41392-020-0110-5 (Q9274) (← links)
- Bjerkvig R, et al. Nat. Rev. Cancer (2005) cited as Ref 12 in DOI: 10.1038/s41392-020-0110-5 (Q9275) (← links)
- Matsui W, et al. Blood (2004) cited as Ref 13 in DOI: 10.1038/s41392-020-0110-5 (Q9276) (← links)
- Hill RP, et al. Cancer Res. (2006) cited as Ref 14 in DOI: 10.1038/s41392-020-0110-5 (Q9277) (← links)
- Huntly BJ, et al. Nat. Rev. Cancer (2005) cited as Ref 15 in DOI: 10.1038/s41392-020-0110-5 (Q9278) (← links)
- Kanwar SS, et al. Mol. Cancer (2010) cited as Ref 16 in DOI: 10.1038/s41392-020-0110-5 (Q9279) (← links)
- Li C, et al. Cancer Res. (2007) cited as Ref 17 in DOI: 10.1038/s41392-020-0110-5 (Q9280) (← links)
- Wang J, et al. Stem Cells (2010) cited as Ref 18 in DOI: 10.1038/s41392-020-0110-5 (Q9281) (← links)